AdvaMed® Q3 2026: Delivering Progress for Patients and the Medtech Community
The Q3 2026 Report highlights AdvaMed®’s continued progress in advancing policies that support innovation, strengthen patient access to medtech, and reinforce the value of medtech across a complex health care environment. Covering regulatory policy, Medicare coverage and payment, digital health, diagnostics, artificial intelligence, cybersecurity, global affairs, and trade policy, this report captures the advocacy, member engagement, and strategic action driving momentum for the medtech industry and patients.
Explore the full Q3 2026 Report to see how AdvaMed® is working with policymakers, regulators, and member companies to advance practical solutions, address emerging policy challenges, and ensure patients can benefit from the next generation of life-changing medtech.